Back
MediPharm Labs 10K Form
Sell
47
MEDIF
MediPharm Labs
Last Price:
0.05
Seasonality Move:
-2.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MEDIF News And Ratings
See the #1 stock for the next 7 days that we like better than MEDIF
MEDIF Financial Statistics
Sales & Book Value
| Annual Sales: | $24.49M |
|---|---|
| Cash Flow: | $-1.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.08 |
| Price / Book: | 0.6 |
Profitability
| EPS (TTM): | -0.02950 |
|---|---|
| Net Income (TTM): | $-9.97M |
| Gross Margin: | $4.34M |
| Return on Equity: | -25.33% |
| Return on Assets: | -20.53% |
MediPharm Labs Earnings Forecast
Key MediPharm Labs Financial Ratios
- The Gross Profit Margin over the past 6 years for MEDIF is 17.71%.
- The Selling, General & Administrative Expenses for MEDIF have been equal to 75.00% of Gross Profit Margin.
- The Research & Development expenses have been 0.63% of Revenue.
- The Interest Expense is -2.79% of Operating Income.
- The Net Earning history of MEDIF is -39.57% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 4 years.
MediPharm Labs Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | MEDIF |
| Website: | medipharmlabs.com |
Debt
| Debt-to-Equity Ratio: | 0.06 |
|---|---|
| Current Ratio: | 3.11 |
| Quick Ratio: | 1.82 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MEDIF Technical Analysis vs Fundamental Analysis
Sell
47
MediPharm Labs (MEDIF)
is a Sell
Is MediPharm Labs a Buy or a Sell?
-
MediPharm Labs stock is rated a Sell
The current MediPharm Labs [MEDIF] share price is $0.05. The Score for MEDIF is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.